deltatrials
Completed NA NCT00302627

Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation

Sponsor: Ochsner Health System

Conditions Transplant Bone Disease
Interventions Calcium Carbonate Pamidronate vitamin D
Updated 6 times since 2017 Last updated: Aug 27, 2018 Started: Jan 31, 1999 Primary completion: Nov 30, 2002 Completion: Nov 30, 2002

Listed as NCT00302627, this NA trial focuses on Transplant Bone Disease and remains completed. Sponsored by Ochsner Health System, it has been updated 6 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Sep 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jun 2018 — Sep 2018 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ochsner Health System
  • Providence Health & Services
  • The Heart Institute of Spokane
  • University of Washington
Data source: Providence Health & Services

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Spokane, United States